| pubmed-article:313223 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:313223 | lifeskim:mentions | umls-concept:C1257890 | lld:lifeskim |
| pubmed-article:313223 | lifeskim:mentions | umls-concept:C0000768 | lld:lifeskim |
| pubmed-article:313223 | lifeskim:mentions | umls-concept:C0023434 | lld:lifeskim |
| pubmed-article:313223 | lifeskim:mentions | umls-concept:C0597357 | lld:lifeskim |
| pubmed-article:313223 | lifeskim:mentions | umls-concept:C1254042 | lld:lifeskim |
| pubmed-article:313223 | lifeskim:mentions | umls-concept:C1533691 | lld:lifeskim |
| pubmed-article:313223 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:313223 | pubmed:dateCreated | 1979-9-25 | lld:pubmed |
| pubmed-article:313223 | pubmed:abstractText | Purified human thymus-derived (T) lymphocytes were analyzed by detection of Fc receptors for either IgG or IgM in healthy controls and in patients with chronic lymphocytic leukemia (CLL). There was a significant and persistent increase in the numbers of T cells bearing receptors for IgG (Fc gamma) in CLL patients in comparison to the controls. After an in vitro culture period, there was a significantly decreased appearance of cells with IgM receptors (Fcmu) in CLL patients in comparison to the control group. These results indicate an imbalance in circulating T-cell subpopulations for CLL patients. In addition, an in vitro defect in CLL T-cell membrane receptor appearance is present. | lld:pubmed |
| pubmed-article:313223 | pubmed:language | eng | lld:pubmed |
| pubmed-article:313223 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:313223 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:313223 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:313223 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:313223 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:313223 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:313223 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:313223 | pubmed:issn | 0006-4971 | lld:pubmed |
| pubmed-article:313223 | pubmed:author | pubmed-author:JohnsonJ DJD | lld:pubmed |
| pubmed-article:313223 | pubmed:author | pubmed-author:KayN ENE | lld:pubmed |
| pubmed-article:313223 | pubmed:author | pubmed-author:DouglasS DSD | lld:pubmed |
| pubmed-article:313223 | pubmed:author | pubmed-author:StanekRR | lld:pubmed |
| pubmed-article:313223 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:313223 | pubmed:volume | 54 | lld:pubmed |
| pubmed-article:313223 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:313223 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:313223 | pubmed:pagination | 540-4 | lld:pubmed |
| pubmed-article:313223 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:313223 | pubmed:meshHeading | pubmed-meshheading:313223-H... | lld:pubmed |
| pubmed-article:313223 | pubmed:meshHeading | pubmed-meshheading:313223-L... | lld:pubmed |
| pubmed-article:313223 | pubmed:meshHeading | pubmed-meshheading:313223-I... | lld:pubmed |
| pubmed-article:313223 | pubmed:meshHeading | pubmed-meshheading:313223-I... | lld:pubmed |
| pubmed-article:313223 | pubmed:meshHeading | pubmed-meshheading:313223-B... | lld:pubmed |
| pubmed-article:313223 | pubmed:meshHeading | pubmed-meshheading:313223-I... | lld:pubmed |
| pubmed-article:313223 | pubmed:meshHeading | pubmed-meshheading:313223-T... | lld:pubmed |
| pubmed-article:313223 | pubmed:year | 1979 | lld:pubmed |
| pubmed-article:313223 | pubmed:articleTitle | T-cell subpopulations in chronic lymphocytic leukemia: abnormalities in distribtuion and in in vitro receptor maturation. | lld:pubmed |
| pubmed-article:313223 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:313223 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:313223 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:313223 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:313223 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:313223 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:313223 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:313223 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:313223 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:313223 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:313223 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:313223 | lld:pubmed |
